JP2022046221A - Dentifrice composition - Google Patents
Dentifrice composition Download PDFInfo
- Publication number
- JP2022046221A JP2022046221A JP2020152154A JP2020152154A JP2022046221A JP 2022046221 A JP2022046221 A JP 2022046221A JP 2020152154 A JP2020152154 A JP 2020152154A JP 2020152154 A JP2020152154 A JP 2020152154A JP 2022046221 A JP2022046221 A JP 2022046221A
- Authority
- JP
- Japan
- Prior art keywords
- salt
- component
- mass
- content
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 239000000551 dentifrice Substances 0.000 title claims abstract description 43
- -1 alkali metal pyrophosphate Chemical class 0.000 claims abstract description 70
- 150000003839 salts Chemical class 0.000 claims abstract description 34
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 14
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 11
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 10
- 235000011180 diphosphates Nutrition 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000003112 inhibitor Substances 0.000 claims description 7
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 4
- 108010077895 Sarcosine Proteins 0.000 claims description 4
- 229940043230 sarcosine Drugs 0.000 claims description 4
- 210000004268 dentin Anatomy 0.000 claims description 2
- 238000003860 storage Methods 0.000 abstract description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 44
- 235000014113 dietary fatty acids Nutrition 0.000 description 22
- 239000000194 fatty acid Substances 0.000 description 22
- 229930195729 fatty acid Natural products 0.000 description 22
- 230000000694 effects Effects 0.000 description 20
- 210000000214 mouth Anatomy 0.000 description 20
- 239000000377 silicon dioxide Substances 0.000 description 20
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 14
- 230000007794 irritation Effects 0.000 description 14
- 238000011156 evaluation Methods 0.000 description 13
- 239000008187 granular material Substances 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 239000002245 particle Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 239000003082 abrasive agent Substances 0.000 description 10
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 239000011230 binding agent Substances 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 9
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 229960003237 betaine Drugs 0.000 description 7
- 239000001506 calcium phosphate Substances 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 229940048084 pyrophosphate Drugs 0.000 description 7
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- 239000003945 anionic surfactant Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 6
- 159000000000 sodium salts Chemical class 0.000 description 6
- 239000000606 toothpaste Substances 0.000 description 6
- 229940034610 toothpaste Drugs 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 150000003863 ammonium salts Chemical class 0.000 description 5
- 229910000389 calcium phosphate Inorganic materials 0.000 description 5
- 235000011010 calcium phosphates Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000000825 pharmaceutical preparation Substances 0.000 description 5
- 229940127557 pharmaceutical product Drugs 0.000 description 5
- 239000011164 primary particle Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 229910021536 Zeolite Inorganic materials 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 4
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 4
- 229940048086 sodium pyrophosphate Drugs 0.000 description 4
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 4
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 239000010457 zeolite Substances 0.000 description 4
- 239000004711 α-olefin Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 125000004442 acylamino group Chemical group 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 150000008051 alkyl sulfates Chemical class 0.000 description 3
- 229910000323 aluminium silicate Inorganic materials 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 3
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 235000017858 Laurus nobilis Nutrition 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 244000125380 Terminalia tomentosa Species 0.000 description 2
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- 150000001484 arginines Chemical class 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical class C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 2
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical class CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000832 lactitol Substances 0.000 description 2
- 235000010448 lactitol Nutrition 0.000 description 2
- 229960003451 lactitol Drugs 0.000 description 2
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 108700004121 sarkosyl Proteins 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 2
- 239000009637 wintergreen oil Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-BDAKNGLRSA-N (-)-menthone Chemical compound CC(C)[C@@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-BDAKNGLRSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical class C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- GRWFGVWFFZKLTI-YGPZHTELSA-N (5r)-4,6,6-trimethylbicyclo[3.1.1]hept-3-ene Chemical compound C1C2CC=C(C)[C@]1([H])C2(C)C GRWFGVWFFZKLTI-YGPZHTELSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- HVNMCCPQUIEPCT-UHFFFAOYSA-N 2-(dimethylazaniumyl)pentanoate Chemical compound CCCC(N(C)C)C(O)=O HVNMCCPQUIEPCT-UHFFFAOYSA-N 0.000 description 1
- LBIZZGIYNNLXQN-UHFFFAOYSA-N 2-dodecoxy-2-oxoethanesulfonic acid Chemical compound CCCCCCCCCCCCOC(=O)CS(O)(=O)=O LBIZZGIYNNLXQN-UHFFFAOYSA-N 0.000 description 1
- HKJKXDULJBGDED-UHFFFAOYSA-N 3-(tetradecylamino)propanoic acid Chemical class CCCCCCCCCCCCCCNCCC(O)=O HKJKXDULJBGDED-UHFFFAOYSA-N 0.000 description 1
- UNWFFCPRJXMCNV-UHFFFAOYSA-N 3-[dodecanoyl(methyl)amino]propanoic acid Chemical class CCCCCCCCCCCC(=O)N(C)CCC(O)=O UNWFFCPRJXMCNV-UHFFFAOYSA-N 0.000 description 1
- DCVMAYAWOPBYKB-UHFFFAOYSA-N 3-[methyl(tetradecanoyl)amino]propanoic acid Chemical class CCCCCCCCCCCCCC(=O)N(C)CCC(O)=O DCVMAYAWOPBYKB-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical class CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- LQKRYVGRPXFFAV-UHFFFAOYSA-N Phenylmethylglycidic ester Chemical compound CCOC(=O)C1OC1(C)C1=CC=CC=C1 LQKRYVGRPXFFAV-UHFFFAOYSA-N 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- XHXUANMFYXWVNG-WCQGTBRESA-N [(1s,2r,5s)-5-methyl-2-propan-2-ylcyclohexyl] acetate Chemical compound CC(C)[C@H]1CC[C@H](C)C[C@@H]1OC(C)=O XHXUANMFYXWVNG-WCQGTBRESA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001294 alanine derivatives Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Chemical class C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 238000011086 high cleaning Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- VSDUZFOSJDMAFZ-VIFPVBQESA-N methyl L-phenylalaninate Chemical compound COC(=O)[C@@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-VIFPVBQESA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940070802 palmitoyl glutamate Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 1
- 229940068886 polyethylene glycol 300 Drugs 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229940095068 tetradecene Drugs 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000011240 wet gel Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
本発明は、歯磨剤組成物に関する。 The present invention relates to a dentifrice composition.
これまでにラウロイルサルコシンナトリウム(LSS)等のアシルサルコシン塩や塩化セチルピリジニウム(CPC)などは殺菌効果を有することが報告されている。例えば、特許文献1には、アシルアミノ酸塩、アルキルアミノ酸塩、水溶性ポリリン酸塩及びポリエチレングリコールを所定量配合してなる歯磨剤組成物は、ステイン付着抑制効果、ステイン除去効果、使用感に優れることが記載されている。特許文献2には、N-アシルアミノ酸又はその塩、ピロリン酸又はその塩を所定の比率で含む口腔用組成物が、タンパク汚れ除去、タンパク汚れの歯面への付着防止、清掃効果を実感させることができることが記載されている。 So far, it has been reported that acylsarcosine salts such as lauroyl sarcosine sodium (LSS) and cetylpyridinium chloride (CPC) have a bactericidal effect. For example, in Patent Document 1, a dentifrice composition containing a predetermined amount of an acyl amino acid salt, an alkyl amino acid salt, a water-soluble polyphosphate and polyethylene glycol is excellent in a stain adhesion suppressing effect, a stain removing effect, and a usability. It is stated that. In Patent Document 2, an oral composition containing N-acylamino acid or a salt thereof, pyrophosphate or a salt thereof in a predetermined ratio realizes the effect of removing protein stains, preventing the adhesion of protein stains to the tooth surface, and cleaning. It is stated that it can be done.
しかし、いずれの従来技術も、刺激感が生じやすく清掃実感の点でも使用感が必ずしも十分ではないと言う問題点があった。また、ピロリン酸ナトリウム等のアルカリ物質を配合すると、刺激感が生じることがあり、また、製剤が経時的にゲル化し保水力が低下して液分離、肌荒れを生じる等、保存安定性が低下することがある。 However, all of the conventional techniques have a problem that a feeling of irritation is likely to occur and the feeling of use is not always sufficient in terms of the actual feeling of cleaning. In addition, when an alkaline substance such as sodium pyrophosphate is added, a feeling of irritation may occur, and the pharmaceutical product gels over time, the water retention capacity decreases, liquid separation and rough skin occur, and the storage stability decreases. Sometimes.
本発明の課題は、使用感が良好であり、さらに、刺激感が抑制され、保存安定性が良好な歯磨剤組成物を提供することにある。 An object of the present invention is to provide a dentifrice composition having a good feeling of use, a feeling of irritation being suppressed, and a good storage stability.
本発明者らは上記課題を解決すべく鋭意検討を重ねた結果、アシルサルコシン類及びピロリン酸アルカリ金属塩の組み合わせが、口腔内のネバつき防止効果を有し清掃実感が高く、かつ長期間発揮でき、使用感が改善されることを見出した。さらに、これらに非イオン界面活性剤とポリエチレングリコールを組み合わせることにより、刺激感が抑制され、保存安定性が良好な歯磨剤組成物を提供することにある。
本発明は、以下の[1]~[7]を提供する。
[1](A)アシルサルコシン又はその塩
(B)ピロリン酸アルカリ金属塩
(C)非イオン界面活性剤、及び
(D)ポリエチレングリコール
を含有する歯磨剤組成物。
[2](A)成分の含有量の(B)成分の含有量に対する比((A)/(B))が0.003~10である、[1]に記載の歯磨剤組成物。
[3](A)成分の含有量の(C)成分の含有量に対する比((A)/(C))が0.002~10である、[1]又は[2]に記載の歯磨剤組成物。
[4](B)成分の含有量の(C)成分の含有量に対する比((B)/(C))が0.02~30である、[1]~[3]のいずれか1項に記載の歯磨剤組成物。
[5](A)アシルサルコシン又はその塩、及び
(B)ピロリン酸アルカリ金属塩
を含有する口腔内のネバつき抑制剤。
[6](C)非イオン界面活性剤を更に含有する、[5]に記載の剤。
[7](D)ポリエチレングリコールを更に含有する、[5]又は[6]に記載の剤。
As a result of diligent studies to solve the above problems, the present inventors have a combination of acyl sarcosine and an alkali metal pyrophosphate having an effect of preventing stickiness in the oral cavity, and have a high cleaning feeling and exhibit for a long period of time. It was found that the usability was improved. Further, by combining these with a nonionic surfactant and polyethylene glycol, it is an object of the present invention to provide a dentifrice composition in which a feeling of irritation is suppressed and storage stability is good.
The present invention provides the following [1] to [7].
[1] A dentin composition containing (A) acylsarcosine or a salt thereof (B) an alkali metal pyrophosphate (C) a nonionic surfactant, and (D) polyethylene glycol.
[2] The dentifrice composition according to [1], wherein the ratio ((A) / (B)) of the content of the component (A) to the content of the component (B) is 0.003 to 10.
[3] The dentifrice according to [1] or [2], wherein the ratio ((A) / (C)) of the content of the component (A) to the content of the component (C) is 0.002 to 10. Composition.
[4] Any one of [1] to [3], wherein the ratio ((B) / (C)) of the content of the component (B) to the content of the component (C) is 0.02 to 30. The dentifrice composition according to.
[5] An oral anti-stickiness inhibitor containing (A) acylsarcosine or a salt thereof, and (B) an alkali metal pyrophosphate.
[6] The agent according to [5], which further contains (C) a nonionic surfactant.
[7] The agent according to [5] or [6], which further contains (D) polyethylene glycol.
本発明によれば、口腔内のネバつき防止効果を有しかつ長期間発揮でき、さらに、刺激感が抑制され、保存安定性が良好な歯磨剤組成物を提供できる。 According to the present invention, it is possible to provide a dentifrice composition which has an effect of preventing stickiness in the oral cavity and can be exerted for a long period of time, further suppresses irritation, and has good storage stability.
以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.
[1.歯磨剤組成物]
歯磨剤組成物は、(A)及び(B)成分を含有し、好ましくは(C)及び(D)成分の少なくともいずれかを更に含有し、より好ましくは(A)~(D)成分を含有する。
[1. Toothpaste composition]
The dentifrice composition contains the components (A) and (B), preferably further contains at least one of the components (C) and (D), and more preferably contains the components (A) to (D). do.
[(A)アシルサルコシン又はその塩]
(A)成分は、アシルサルコシン又はその塩である。(A)成分を含有することにより、口腔内のネバつき除去効果が発揮され得る。
[(A) Acylsarcosine or a salt thereof]
The component (A) is acylsarcosine or a salt thereof. By containing the component (A), the effect of removing stickiness in the oral cavity can be exhibited.
-アシルサルコシン及びその塩の例-
アシルサルコシンが有するアシル基の炭素原子数は、通常は10~18、好ましくは10~16である。アシル基は鎖状(直鎖、分岐鎖)、環状のいずれでもよく、飽和及び不飽和のいずれでもよい。好ましくは鎖状である。アシル基としては、例えば、ラウロイル基、ミリストイル基、パルミトイル基、ステアロイル基が挙げられ、ラウロイル基が好ましい。アシルサルコシンが塩の形態である場合、薬理学的に許容される塩であればよい。薬理学的に許容される塩としては、例えば、塩基付加塩及びアミノ酸塩が挙げられる。その具体例としては、ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩、アンモニウム塩等の無機塩基塩;トリエチルアンモニウム塩、トリエタノールアンモニウム塩、ピリジニウム塩、ジイソプロピルアンモニウム塩等の有機塩基塩;アルギニン塩等の塩基性アミノ酸塩が挙げられる。中でも、無機塩基塩が好ましく、アルカリ金属塩又はアンモニウム塩がより好ましく、ナトリウム塩が更に好ましい。
-Examples of acyl sarcosine and its salts-
The number of carbon atoms of the acyl group contained in acyl sarcosine is usually 10 to 18, preferably 10 to 16. The acyl group may be chain-like (straight chain, branched chain) or cyclic, and may be saturated or unsaturated. It is preferably chain-shaped. Examples of the acyl group include a lauroyl group, a myristoyl group, a palmitoyl group, and a stearoyl group, and a lauroyl group is preferable. When acylsarcosine is in the form of a salt, it may be any pharmacologically acceptable salt. Pharmacologically acceptable salts include, for example, base addition salts and amino acid salts. Specific examples thereof include inorganic base salts such as sodium salt, potassium salt, calcium salt, magnesium salt and ammonium salt; organic base salts such as triethylammonium salt, triethanolammonium salt, pyridinium salt and diisopropylammonium salt; arginine salt and the like. Basic amino acid salts of. Among them, an inorganic base salt is preferable, an alkali metal salt or an ammonium salt is more preferable, and a sodium salt is further preferable.
(A)成分は、アシルサルコシン及びその塩から選ばれる1種単独でもよいし、2種以上の組み合わせでもよいが、少なくともラウロイルサルコシン又はその塩を含むことが好ましく、ラウロイルサルコシンナトリウムを含むことがより好ましい。 The component (A) may be one selected from acylsarcosine and a salt thereof alone or a combination of two or more thereof, but preferably contains at least lauroyl sarcosine or a salt thereof, and more preferably contains sodium lauroyl sarcosine. preferable.
-(A)成分の含有量-
(A)成分の含有量は、組成物の全量に対し、通常、0.01質量%以上、好ましくは0.05質量%以上である。これにより、(A)成分を配合することによる効果を十分に発揮できる。上限は、通常、3質量%以下、好ましくは1質量%以下、より好ましくは0.5質量%以下である。これにより、刺激感を良好に抑制できる。従って、(A)成分の含有量は、通常、0.01~3質量%、好ましくは0.01~1質量%、より好ましくは0.05~0.5質量%である。
-Contents of (A) component-
The content of the component (A) is usually 0.01% by mass or more, preferably 0.05% by mass or more, based on the total amount of the composition. As a result, the effect of blending the component (A) can be fully exhibited. The upper limit is usually 3% by mass or less, preferably 1% by mass or less, and more preferably 0.5% by mass or less. As a result, the feeling of irritation can be satisfactorily suppressed. Therefore, the content of the component (A) is usually 0.01 to 3% by mass, preferably 0.01 to 1% by mass, and more preferably 0.05 to 0.5% by mass.
本明細書において、各成分の含有量は、組成物を製造する際の各成分の仕込み量を基準とするものである。 In the present specification, the content of each component is based on the amount of each component charged in producing the composition.
[(B)ピロリン酸アルカリ金属塩]
(B)成分は、ピロリン酸アルカリ金属塩である。(B)成分を含有することにより、口内のネバつき除去効果が増強され得る。ピロリン酸の塩を形成するアルカリ金属イオンとしては、例えば、ナトリウムイオン、カリウムイオンが挙げられ、ナトリウムイオンが好ましい。
[(B) Pyrophosphate alkali metal salt]
The component (B) is an alkali metal pyrophosphate. By containing the component (B), the effect of removing stickiness in the mouth can be enhanced. Examples of the alkali metal ion forming a salt of pyrophosphate include sodium ion and potassium ion, and sodium ion is preferable.
-(B)成分の含有量-
(B)成分の含有量は、組成物の全量に対し、通常、0.01質量%以上、好ましくは0.1質量%以上、より好ましくは0.3質量%以上である。これにより、(B)成分を配合することによる効果を十分に発揮できる。上限は、通常、5質量%以下、好ましくは3質量%以下、より好ましくは1.5質量%以下である。これにより、刺激感を良好に抑制できる。従って、(B)成分の含有量は、通常、0.01~5質量%、好ましくは0.1~3質量%、より好ましくは0.3~1.5質量%である。
-Contents of (B) component-
The content of the component (B) is usually 0.01% by mass or more, preferably 0.1% by mass or more, and more preferably 0.3% by mass or more with respect to the total amount of the composition. As a result, the effect of blending the component (B) can be fully exhibited. The upper limit is usually 5% by mass or less, preferably 3% by mass or less, and more preferably 1.5% by mass or less. As a result, the feeling of irritation can be satisfactorily suppressed. Therefore, the content of the component (B) is usually 0.01 to 5% by mass, preferably 0.1 to 3% by mass, and more preferably 0.3 to 1.5% by mass.
[(C)ノニオン界面活性剤]
(C)成分は、ノニオン界面活性剤である。(C)成分を含有することにより、刺激低減効果を得ることができる。
[(C) Nonionic Surfactant]
The component (C) is a nonionic surfactant. By containing the component (C), an irritation reducing effect can be obtained.
-ノニオン界面活性剤の例-
ノニオン界面活性剤としては、例えば、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル(例、ポリオキシエチレンソルビタンモノステアレート)、アルキロールアミド、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンアルケニルエーテル、グリセリン脂肪酸エステル、ショ糖脂肪酸エステル(例、マルトース脂肪酸エステル)、糖アルコール脂肪酸エステル(例、マルチトール脂肪酸エステル、ラクチトール脂肪酸エステル)、脂肪酸ジエタノールアミド(例、ラウリル酸モノ又はジエタノールアミド)、ポリオキシエチレンポリオキシプロピレン共重合体、ポリオキシエチレンポリオキシプロピレン脂肪酸エステルが挙げられる。ポリオキシエチレンアルキルエーテルのアルキル鎖の炭素原子数は、通常、14~18であり、エチレンオキサイド平均付加モル数は、通常、15~30モルである。ポリオキシエチレン硬化ヒマシ油のエチレンオキサイド平均付加モル数は、通常20~100モル、好ましくは20~60モルである。ソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常12~18である。ポリオキシエチレンソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常16~18であり、エチレンオキサイド平均付加モル数は、通常10~40モルである。アルキロールアミドのアルキル鎖の炭素原子数は、通常12~14である。ノニオン界面活性剤としては、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンアルキルエーテルが好ましい。
-Example of nonionic surfactant-
Examples of the nonionic surfactant include polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester (eg, polyoxyethylene sorbitan monostearate), alkylolamide, and polyoxy. Ethylene fatty acid ester, polyoxyethylene alkenyl ether, glycerin fatty acid ester, sucrose fatty acid ester (eg, maltose fatty acid ester), sugar alcohol fatty acid ester (eg, multitoll fatty acid ester, lactitol fatty acid ester), fatty acid diethanolamide (eg, lauryl). Acid mono or diethanolamide), polyoxyethylene polyoxypropylene copolymer, polyoxyethylene polyoxypropylene fatty acid ester, and the like. The number of carbon atoms in the alkyl chain of the polyoxyethylene alkyl ether is usually 14 to 18, and the average number of moles of ethylene oxide added is usually 15 to 30 mol. The average number of moles of ethylene oxide added to the polyoxyethylene hydrogenated castor oil is usually 20 to 100 mol, preferably 20 to 60 mol. The number of carbon atoms of the fatty acid of the sorbitan fatty acid ester is usually 12 to 18. The fatty acid of the polyoxyethylene sorbitan fatty acid ester usually has 16 to 18 carbon atoms, and the average number of moles of ethylene oxide added is usually 10 to 40 mol. The number of carbon atoms in the alkyl chain of the alkylolamide is usually 12 to 14. As the nonionic surfactant, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, and polyoxyethylene alkyl ether are preferable.
-(C)成分の含有量-
(C)成分の含有量は、組成物の全量に対し、通常、0.01質量%以上、好ましくは0.1質量%以上、より好ましくは0.2質量%以上である。これにより、(C)成分の効果を十分発揮できる。上限は、通常、10質量%以下、好ましくは5質量%以下、より好ましくは3質量%以下である。これにより、ノニオン界面活性剤特有の異味の発生が抑制でき、油っぽい風味となり使用感が低下するおそれを抑制できる。従って、(C)成分の含有量は、通常、0.01~10質量%、好ましくは0.1~5質量%、より好ましくは0.2~3質量%である。
-Contents of (C) component-
The content of the component (C) is usually 0.01% by mass or more, preferably 0.1% by mass or more, and more preferably 0.2% by mass or more with respect to the total amount of the composition. As a result, the effect of the component (C) can be fully exerted. The upper limit is usually 10% by mass or less, preferably 5% by mass or less, and more preferably 3% by mass or less. As a result, it is possible to suppress the generation of an off-flavor peculiar to the nonionic surfactant, and it is possible to suppress the possibility that the oily flavor will be obtained and the usability will be deteriorated. Therefore, the content of the component (C) is usually 0.01 to 10% by mass, preferably 0.1 to 5% by mass, and more preferably 0.2 to 3% by mass.
[(D)ポリエチレングリコール]
(D)成分は、ポリエチレングリコールである。(D)成分を含有することにより、製剤安定性を向上させることができる。
[(D) Polyethylene glycol]
The component (D) is polyethylene glycol. By containing the component (D), the stability of the pharmaceutical product can be improved.
ポリエチレングリコールの平均分子量は、650以下、好ましくは600以下であり、より好ましくは150~650、更に好ましくは250~600である。ポリエチレングリコールとしては、例えば、ポリエチレングリコール200(平均分子量190~210)、ポリエチレングリコール300(平均分子量280~320)、ポリエチレングリコール400(平均分子量380~420)、ポリエチレングリコール600(平均分子量570~630)が挙げられ、市販品でもよい。本明細書において、ポリエチレングリコールの平均分子量は、医薬部外品原料規格2006記載の平均分子量である。 The average molecular weight of polyethylene glycol is 650 or less, preferably 600 or less, more preferably 150 to 650, and even more preferably 250 to 600. Examples of polyethylene glycol include polyethylene glycol 200 (average molecular weight 190 to 210), polyethylene glycol 300 (average molecular weight 280 to 320), polyethylene glycol 400 (average molecular weight 380 to 420), and polyethylene glycol 600 (average molecular weight 570 to 630). However, it may be a commercially available product. In the present specification, the average molecular weight of polyethylene glycol is the average molecular weight described in the Quasi-drug Raw Material Standard 2006.
-(D)成分の含有量-
(D)成分の含有量は、組成物の全量に対し、通常、0.1質量%以上、好ましくは0.5質量%以上、より好ましくは1質量%以上である。これを下回ると、練肌が不十分となるおそれがある。上限は、通常、10質量%以下、好ましくは5質量%以下、より好ましくは3質量%以下である。これを上回ると、液分離が発生するおそれがある。従って、(D)成分の含有量は、通常、0.1~10質量%、好ましくは0.5~5質量%、より好ましくは1~3質量%である。
-Contents of (D) component-
The content of the component (D) is usually 0.1% by mass or more, preferably 0.5% by mass or more, and more preferably 1% by mass or more with respect to the total amount of the composition. If it is less than this, the kneaded skin may be insufficient. The upper limit is usually 10% by mass or less, preferably 5% by mass or less, and more preferably 3% by mass or less. If it exceeds this, liquid separation may occur. Therefore, the content of the component (D) is usually 0.1 to 10% by mass, preferably 0.5 to 5% by mass, and more preferably 1 to 3% by mass.
[含有比率]
-(A)/(B)-
(A)成分の含有量の(B)成分の含有量に対する比((A)/(B))は、通常、0.001~20、好ましくは0.003~10、より好ましくは0.05~1である。これにより、口腔内のネバつき抑制効果が発揮されかつ長期間持続でき、口腔内刺激感が抑制され、さらに、液分離の抑制、良好なペーストの練肌等の外観が保存後も良好である等、保存安定性効果を得ることができる。
[Content ratio]
-(A) / (B)-
The ratio ((A) / (B)) of the content of the component (A) to the content of the component (B) is usually 0.001 to 20, preferably 0.003 to 10, more preferably 0.05. ~ 1. As a result, the effect of suppressing stickiness in the oral cavity is exhibited and can be sustained for a long period of time, the feeling of irritation in the oral cavity is suppressed, and the appearance such as suppression of liquid separation and good paste of kneaded skin is good even after storage. Etc., a storage stability effect can be obtained.
-(A)/(C)-
(A)成分の含有量の(C)成分の含有量に対する比((A)/(C))は、通常、0.001~15、好ましくは0.002~10、より好ましくは0.05~1である。これにより、口腔内のネバつき抑制効果が発揮されかつ長期間持続でき、口腔内刺激感が抑制される等の効果を得ることができる。
-(A) / (C)-
The ratio ((A) / (C)) of the content of the component (A) to the content of the component (C) is usually 0.001 to 15, preferably 0.002 to 10, more preferably 0.05. ~ 1. As a result, the effect of suppressing stickiness in the oral cavity can be exerted and can be sustained for a long period of time, and the effect of suppressing the feeling of irritation in the oral cavity can be obtained.
-(B)/(C)-
(B)成分の含有量の(C)成分の含有量に対する比((B)/(C))は、通常、0.01~50、好ましくは0.02~30、より好ましくは0.3~4である。これにより、口腔内のネバつき抑制効果が発揮されかつ長期間持続できる。
-(B) / (C)-
The ratio ((B) / (C)) of the content of the component (B) to the content of the component (C) is usually 0.01 to 50, preferably 0.02 to 30, more preferably 0.3. ~ 4. As a result, the effect of suppressing stickiness in the oral cavity is exhibited and it can be sustained for a long period of time.
[任意成分]
歯磨剤組成物は、本発明の効果を損なわない範囲で、(A)~(D)成分以外の他の成分を含有してもよい。他の成分としては、例えば、研磨剤、粘結剤、界面活性剤、湿潤剤、甘味剤、香料、pH調整剤、防腐剤、薬効成分、着色剤(色素)、溶剤等の歯磨剤組成物に配合され得る成分が挙げられるが、これらに限定されない。
[Arbitrary ingredient]
The dentifrice composition may contain components other than the components (A) to (D) as long as the effects of the present invention are not impaired. Examples of other components include dentifrice compositions such as abrasives, binders, surfactants, wetting agents, sweeteners, fragrances, pH regulators, preservatives, medicinal ingredients, colorants (pigments), and solvents. Ingredients that can be incorporated into, but are not limited to these.
-研磨剤-
研磨剤としては、例えば、第2リン酸カルシウム・2水和塩又は無水和物、第1リン酸カルシウム、第3リン酸カルシウム、ピロリン酸カルシウム、不溶性メタリン酸カルシウム、第3リン酸カルシウム、第4リン酸カルシウム、第8リン酸カルシウム等のリン酸カルシウム系化合物;沈降性シリカ、アルミノシリケート、ジルコノシリケート、チタン結合性シリカ、シリカゲル等のシリカ系研磨剤;炭酸カルシウム(軽質、重質)等の炭酸カルシウム系研磨剤;水酸化アルミニウム、アルミナ等のアルミニウム系研磨剤;炭酸マグネシウム、第3リン酸マグネシウム等のマグネシウム系研磨剤;無水ケイ酸、ゼオライト、ケイ酸ジルコニウム等のケイ酸系研磨剤;ハイドロキシアパタイト、フルオロアパタイト、カルシウム欠損アパタイト等のアパタイト系研磨剤;水酸化カルシウム;硫酸カルシウム、ベントナイト;二酸化チタン;結晶性ジルコニウムシリケート;ポリメチルメタアクリレート;合成樹脂系研磨剤が挙げられ、好ましくはシリカ系研磨剤、より好ましくは沈降性シリカ、アルミノシリケート、ジルコノシリケート、チタン結合性シリカ等のケイ酸塩を主成分とするシリカ系研磨剤、更に好ましくは沈降性シリカである。沈降性シリカは、平均粒子径が1~40μm、BET比表面積が1gあたり80~250m2の少なくともいずれかを満たすものが好ましい。研磨剤は、これらの1種でもよいし、2種以上の組み合わせでもよい。平均粒子径は、粒度分布測定装置(日機装(株)製、マイクロトラック粒度分布計、分散媒;水)により測定でき、実施例に示す平均粒子径も同様である。
-Abrasive-
As the polishing agent, for example, calcium phosphate-based such as dibasic calcium phosphate dihydrate or anhydrous, first calcium phosphate, tertiary calcium phosphate, calcium pyrophosphate, insoluble calcium metaphosphate, third calcium phosphate, fourth calcium phosphate, eighth calcium phosphate and the like. Compounds; Silica-based abrasives such as precipitated silica, aluminosilicate, zirconosilicate, titanium-binding silica, silica gel; calcium carbonate-based abrasives such as calcium carbonate (light and heavy); aluminum such as aluminum hydroxide and alumina Based-based abrasives; Magnesium-based abrasives such as magnesium carbonate and tertiary magnesium phosphate; Silica-based abrasives such as anhydrous silicic acid, zeolite, and zirconium silicate; Apatite-based abrasives such as hydroxyapatite, fluoroapatite, and calcium-deficient apatite. Agents; calcium hydroxide; calcium sulfate, bentonite; titanium dioxide; crystalline zirconium silicates; polymethylmethacrylate; synthetic resin-based abrasives, preferably silica-based abrasives, more preferably precipitated silica, aluminosilicates, A silica-based abrasive containing a silicate as a main component, such as zirconosilicate and titanium-binding silica, more preferably precipitating silica. The precipitating silica preferably has an average particle size of 1 to 40 μm and a BET specific surface area of 80 to 250 m 2 per gram. The abrasive may be one of these or a combination of two or more. The average particle size can be measured with a particle size distribution measuring device (Microtrak particle size distribution meter, dispersion medium; water) manufactured by Nikkiso Co., Ltd., and the average particle size shown in the examples is also the same.
研磨剤は、顆粒剤(例えば、研磨成分である水不溶性粉体を顆粒状に造粒してなる粒子)でもよい。顆粒剤は、研磨成分を粒状化して調製でき、粒状化の際結合剤を用いてもよい。水不溶性粉体としては、例えば、第2リン酸カルシウム、第3リン酸カルシウム、水不溶性メタリン酸カルシウム、シリカ、水酸化アルミニウム、リン酸マグネシウム、ベンガラ、炭酸カルシウム、ピロリン酸カルシウム、ゼオライト、アルミノ珪酸塩、炭酸マグネシウム、ジルコノシリケート、硫酸カルシウム等の無機粉体、これらから選ばれる2以上の組み合わせが挙げられ、好ましくは、シリカ、ゼオライトである。顆粒剤の体積平均粒径(メジアン径d50)は、50~500μmが好ましい。本明細書において、体積平均粒径は、粒度分布測定装置(日機装(株)製、マイクロトラック粒度分布計、分散媒;水)による測定値である。顆粒剤の平均崩壊強度は、10~200g/個が好ましい。本明細書において、平均崩壊強度は、レオメーター(サンレオメーターCR-200D、サン科学社製)による、顆粒30個の自動破断強度測定値(顆粒1個を10mm/分の速度で圧縮した時に崩壊する時の荷重)の平均値である。 The abrasive may be granules (for example, particles obtained by granulating water-insoluble powder which is an abrasive component into granules). The granule can be prepared by granulating the polishing component, and a binder may be used at the time of granulation. Examples of the water-insoluble powder include dicalcium phosphate, tricalcium phosphate, water-insoluble calcium metaphosphate, silica, aluminum hydroxide, magnesium phosphate, red iron oxide, calcium carbonate, calcium pyrophosphate, zeolite, aluminosilicate, magnesium carbonate, and gills. Examples thereof include inorganic powders such as conosilicate and calcium sulfate, and a combination of two or more selected from these, preferably silica or zeolite. The volume average particle size (median diameter d50) of the granules is preferably 50 to 500 μm. In the present specification, the volume average particle size is a measured value by a particle size distribution measuring device (Microtrak particle size distribution meter manufactured by Nikkiso Co., Ltd., dispersion medium; water). The average disintegration strength of the granules is preferably 10 to 200 g / piece. In the present specification, the average disintegration strength is an automatic breaking strength measurement value of 30 granules (when one granule is compressed at a rate of 10 mm / min) by a leometer (Sun Leometer CR-200D, manufactured by Sun Kagaku Co., Ltd.). It is the average value of the load when collapsing).
シリカ顆粒剤としては、例えば、湿式法のゲル法シリカ、沈降法シリカが好適に用いられ、一次粒子径は3~15nm程度、好ましくは4~10nmが良好である。シリカ加硫剤の製造方法としては、例えば、ゲル法で4~10nm程度まで一次粒子径を成長させたシリカゲルの塊を洗浄、乾燥させた後に粉砕しシリカ顆粒(平均粒径が、例えば50~500μm)に分級する方法、シリカヒドロゾルを空気中に噴霧させゲル化させることで顆粒を調製する方法、沈降法で一次粒子の成長を抑えながら凝集させた後に一次粒子径を成長させる(例えば、一次粒子径が4~10nm程度となるまで成長させる)方法などが知られており、これらの方法でシリカ顆粒剤を調製できる。顆粒剤は着色されていてもよい。研磨剤の含有量は、組成物全体の8~70質量%が好ましい。研磨剤が顆粒剤である場合の含有量は、組成物全体の0.1~20質量%が好ましい。 As the silica granules, for example, wet gel method silica and precipitation method silica are preferably used, and the primary particle size is preferably about 3 to 15 nm, preferably 4 to 10 nm. As a method for producing a silica solaceant, for example, a mass of silica gel whose primary particle size has been grown to about 4 to 10 nm by a gel method is washed, dried, and then pulverized to obtain silica granules (average particle size is, for example, 50 to 50 to). A method of classifying into 500 μm), a method of preparing granules by spraying silica gel hydrosol in the air and gelling, and a method of precipitating to grow the primary particle size after aggregating while suppressing the growth of the primary particles (for example). Methods such as (growing until the primary particle size becomes about 4 to 10 nm) are known, and silica gel granules can be prepared by these methods. The granules may be colored. The content of the abrasive is preferably 8 to 70% by mass of the entire composition. When the abrasive is a granule, the content is preferably 0.1 to 20% by mass of the entire composition.
-粘結剤-
粘結剤としては、例えば、セルロース系粘結剤(例えば、カルボキシメチルセルロースナトリウム、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、カチオン化セルロース等)、カラギーナン、キサンタンガム、グアガム、トラガントガム、カラヤガム、アラビヤガム、ローカストビーンガム、アルギン酸ナトリウム、モンモリロナイト、ポリアクリル酸ナトリウム、ポリビニルピロリドン、ポリビニルアルコール、カルボキシビニルポリマー(商品名:カーボポール)、アルギン酸プロピレングリコール等の有機粘結剤;増粘性シリカ、ケイ酸アルミニウム等の無機粘結剤が挙げられる。粘結剤の含有量は、組成物全体の0.1~10質量%が好ましく、1.4~8質量%がより好ましい。
-Blotting agent-
Examples of the binder include cellulose-based binders (for example, sodium carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, methyl cellulose, cationized cellulose, etc.), carrageenan, xanthan gum, guagam, tragant gum, karaya gum, and arabiya gum. , Locust bean gum, sodium alginate, montmorillonite, sodium polyacrylate, polyvinylpyrrolidone, polyvinyl alcohol, carboxyvinyl polymer (trade name: Carbopol), organic binders such as propylene glycol alginate; thickening silica, aluminum silicate, etc. Inorganic binders can be mentioned. The content of the binder is preferably 0.1 to 10% by mass, more preferably 1.4 to 8% by mass, based on the whole composition.
-界面活性剤-
界面活性剤としては、例えば、アニオン界面活性剤、両性界面活性剤が挙げられる。
アニオン界面活性剤としては、例えば、アルキル硫酸塩、(A)成分以外のアシルアミノ酸塩、アシルタウリン塩、α-オレフィンスルホン酸塩、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸塩、ラウリルスルホ酢酸塩が挙げられる。アルキル基、アシル基は直鎖及び分岐鎖のいずれでもよく、飽和及び不飽和のいずれでもよく、その炭素原子数は通常10~20、好ましくは12~18、特に好ましくは12~14である。塩は、薬理学的に許容される塩から選択され得る。薬理学的に許容される塩としては、例えば、塩基付加塩及びアミノ酸塩が挙げられる。その具体例としては、ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩、アンモニウム塩等の無機塩基塩;トリエチルアンモニウム塩、トリエタノールアンモニウム塩、ピリジニウム塩、ジイソプロピルアンモニウム塩等の有機塩基塩;アルギニン塩等の塩基性アミノ酸塩が挙げられる。中でも、無機塩基塩が好ましく、アルカリ金属塩(例えば、ナトリウム塩、カリウム塩)又はアンモニウム塩がより好ましく、ナトリウム塩が更に好ましい。
-Surfactant-
Examples of the surfactant include an anionic surfactant and an amphoteric surfactant.
Examples of the anionic surfactant include an alkyl sulfate, an acyl amino acid salt other than the component (A), an acyl taurine salt, an α-olefin sulfonate, a hydrogenated coconut fatty acid monoglyceride monosulfate, and a lauryl sulfoacetate. .. The alkyl group and the acyl group may be either a straight chain or a branched chain, and may be saturated or unsaturated, and the number of carbon atoms thereof is usually 10 to 20, preferably 12 to 18, particularly preferably 12 to 14. The salt can be selected from pharmacologically acceptable salts. Pharmacologically acceptable salts include, for example, base addition salts and amino acid salts. Specific examples thereof include inorganic base salts such as sodium salt, potassium salt, calcium salt, magnesium salt and ammonium salt; organic base salts such as triethylammonium salt, triethanolammonium salt, pyridinium salt and diisopropylammonium salt; arginine salt and the like. Basic amino acid salts of. Of these, inorganic base salts are preferred, alkali metal salts (eg, sodium salts, potassium salts) or ammonium salts are more preferred, and sodium salts are even more preferred.
アルキル硫酸塩としては、例えば、ラウリル硫酸塩、ミリストイル硫酸塩が挙げられる。アシルアミノ酸塩としては、例えば、ラウロイルグルタミン酸塩;ミリストイルグルタミン酸塩、パルミトイルグルタミン酸塩等のアシルグルタミン酸塩;N-ラウロイル-N-メチルグリシン塩、ココイルグリシン塩等のアシルグリシン塩;N-ラウロイル-β-アラニン塩、N-ミリスチル-β-アラニン塩、N-ココイル-β-アラニン塩、N-ラウロイル-N-メチル-β-アラニン塩、N-ミリストイル-N-メチル-β-アラニン塩、N-メチル-N-アシルアラニン塩等のアシルアラニン塩;ラウロイルアスパラギン酸塩等のアシルアスパラギン酸塩が挙げられる。アシルタウリン塩としては、例えば、ラウロイルメチルタウリン塩、N-メチル-N-アシルタウリン塩、N-ココイルメチルタウリン塩が挙げられる。α-オレフィンスルホン酸塩としては、テトラデセンスルホン酸塩等の炭素原子数12~14のα-オレフィンスルホン酸塩が挙げられる。アニオン界面活性剤の他の例としては、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸ナトリウム、ラウリルスルホ酢酸ナトリウムが挙げられる。 Examples of the alkyl sulfate include lauryl sulfate and myristoyl sulfate. Examples of the acyl amino acid salt include lauroyl glutamate; acyl glutamate such as myritoyl glutamate and palmitoyl glutamate; acylglycine salt such as N-lauroyl-N-methylglycine salt and cocoylglycine salt; N-lauroyl-β-. Alanine salt, N-myristyl-β-alanine salt, N-cocoyl-β-alanine salt, N-lauroyl-N-methyl-β-alanine salt, N-myristoyl-N-methyl-β-alanine salt, N-methyl Acylalanine salts such as -N-acylalanine salt; acylasparaginates such as lauroyl asparagate can be mentioned. Examples of the acyl taurine salt include lauroylmethyl taurine salt, N-methyl-N-acyl taurine salt, and N-cocoyl methyl taurine salt. Examples of the α-olefin sulfonate include α-olefin sulfonates having 12 to 14 carbon atoms such as tetradecene sulfonate. Other examples of anionic surfactants include hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate.
アニオン界面活性剤は、泡立ち、泡質の良さの点で、スルホン酸基を含有することが好ましく、アルキル硫酸塩、α-オレフィンスルホン酸塩がより好ましい。アニオン界面活性剤の含有量は、好ましくは組成物全体の0.1~2.5質量%、より好ましくは0.6~2.5質量%、更に好ましくは1~2.5質量%である。 The anionic surfactant preferably contains a sulfonic acid group in terms of foaming and good foam quality, and an alkyl sulfate and an α-olefin sulfonate are more preferable. The content of the anionic surfactant is preferably 0.1 to 2.5% by mass, more preferably 0.6 to 2.5% by mass, still more preferably 1 to 2.5% by mass of the entire composition. ..
両性界面活性剤としては、例えば、アルキルジメチルアミノ酢酸ベタイン(例えば、ラウリルジメチルアミノ酢酸ベタイン)、脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン(例えば、コカミドプロピルベタイン)等のベタイン型両性界面活性剤;N-脂肪酸アシル-N-カルボキシメチル-N-ヒドロキシエチルエチレンジアミン塩(例えば、N-ヤシ油脂肪酸アシル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン)、ヤシ油脂肪酸イミダゾリニウムベタイン、2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン等のイミダゾリン型両性界面活性剤;ラウリルジメチルアミノ酢酸ベタイン等のアルキルベタインが挙げられる。カチオン界面活性剤としては、例えば、アルキルアンモニウム塩、アルキルベンジルアンモニウム塩が挙げられる。両性界面活性剤、カチオン界面活性剤を含む場合、それぞれの含有量は、組成物の全量に対し好ましくは、0.1~3質量%である。 Examples of the amphoteric surfactant include betaine-type amphoteric surfactants such as alkyldimethylaminoacetic acid betaine (eg, lauryldimethylaminoacetic acid betaine) and fatty acid amide propyldimethylaminoacetic acid betaine (eg, cocamidopropyl betaine); N-. Fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine salt (eg, N-palm oil fatty acid acyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine), coconut oil fatty acid imidazolinium betaine, 2-alkyl Examples include imidazoline-type amphoteric surfactants such as -N-carboxymethyl-N-hydroxyethyl imidazolinium betaine; alkyl betaines such as lauryldimethylaminoacetic acid betaine. Examples of the cationic surfactant include an alkylammonium salt and an alkylbenzylammonium salt. When the amphoteric tenside agent and the cationic surfactant are contained, the content of each is preferably 0.1 to 3% by mass with respect to the total amount of the composition.
-甘味料-
組成物が甘味剤を含むことにより、使用感をより向上させることができる。甘味剤としては、例えば、キシリトール、エリスリトール、マルチトール、サッカリン、サッカリンナトリウム、アスパルテーム、ステビオサイド、ステビアエキス、パラメトキシシンナミックアルデヒド、ネオヘスペリジンジヒドロカルコン、ペリラルチン、グリチルリチン、ソーマチン、アスパラチルフェニルアラニンメチルエステル等が挙げられる。甘味剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
-sweetener-
When the composition contains a sweetener, the feeling of use can be further improved. Examples of the sweetener include xylitol, erythritol, maltitol, saccharin, saccharin sodium, aspartame, stebioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine, glycyrrhizin, thaumatin, aspartame phenylalanine methyl ester and the like. Will be. The sweetener may be used alone or in combination of two or more.
-湿潤剤-
組成物が湿潤剤を含むことにより、使用感をより向上させることができる。湿潤剤としては、(C)成分以外の多価アルコールが好ましく、例えば、ソルビトール、エリスリトール、マルチトール、ラクチトール、キシリトール等の糖アルコール;グリセリン;プロピレングリコール、エチレングリコール等のグリコール;還元でんぷん糖化物が挙げられる。湿潤剤の含有量は、通常、5~50質量%、好ましくは20~45質量%である。
-Wetting agent-
When the composition contains a wetting agent, the feeling of use can be further improved. As the wetting agent, polyhydric alcohols other than the component (C) are preferable, and for example, sugar alcohols such as sorbitol, erythritol, maltitol, lactitol, and xylitol; glycerin; glycols such as propylene glycol and ethylene glycol; and reduced starch saccharified products. Can be mentioned. The content of the wetting agent is usually 5 to 50% by mass, preferably 20 to 45% by mass.
-香料-
組成物が香料を含むことにより、使用感をより向上させることができる。香料としては、例えば、ペパーミント油、スペアミント油、ユーカリ油、ウィンターグリーン油、クローブ油、タイム油、セージ油、カルダモン油、ローズマリー油、マジョラム油、レモン油、オレンジ油、ナツメグ油、ラベンダー油、パラクレス油、桂皮油、ピメント油、桂葉油、シソ油、冬緑油等の天然精油;メントール、カルボン、シンナミックアルデヒド、アネトール、1,8-シネオール、メチルサリシレート、オイゲノール、チモール、リナロール、リモネン、メントン、メンチルアセテート、シトラール、カンファー、ボルネオール、ピネン、スピラントール、n-デシルアルコール、シトロネロール、α-テルピネオール、シトロネリルアセテート、シネオール、エチルリナロール、ワニリン等の上記天然精油中に含まれる香料成分;エチルアセテート、エチルブチレート、イソアミルアセテート、ヘキサナール、ヘキセナール、メチルアンスラニレート、エチルメチルフェニルグリシデート、ベンズアルデヒド、バニリン、エチルバニリン、フラネオール、N-エチル-p-メンタン-3-カルボキサミド、メンチルラクテート、エチレングリコール-l-メンチルカーボネート等の香料成分;及びいくつかの香料成分や天然精油を組み合わせてなるミント系、フルーツ系、ハーブ系等の各種調合フレーバーが挙げられる。香料は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
-Fragrance-
When the composition contains a fragrance, the feeling of use can be further improved. Examples of fragrances include peppermint oil, sparemint oil, eucalyptus oil, winter green oil, clove oil, thyme oil, sage oil, cardamon oil, rosemary oil, majorum oil, lemon oil, orange oil, nutmeg oil, and lavender oil. Natural essential oils such as parlacles oil, laurel oil, piment oil, laurel oil, perilla oil, winter green oil; menthol, carboxylic, synamic aldehyde, anetol, 1,8-cineole, methyl salicylate, eugenol, timole, linalol, limonen, Perfume components contained in the above natural essential oils such as menthon, mentholacetate, citral, camphor, borneol, pinen, spirantol, n-decyl alcohol, citronellol, α-terpineol, citronellyl acetate, cineol, ethyllinalol, varnish and the like; ethyl acetate , Ethylbutyrate, isoamylacetate, hexanal, hexenal, methylanthranilate, ethylmethylphenylglycidate, benzaldehyde, vanillin, ethylvaniline, flaneol, N-ethyl-p-menthan-3-carboxamide, mentyllactate, ethyleneglycol- Fragrance components such as l-mentyl carbonate; and various blended flavors such as mint-based, fruit-based, and herb-based, which are a combination of several fragrance components and natural essential oils. The fragrance may be used alone or in combination of two or more.
-pH調整剤-
組成物がpH調整剤を含むことにより、製剤のpH安定性を確保できる。pH調整剤としては、例えば、フタル酸、クエン酸、コハク酸、酢酸、フマル酸、リンゴ酸、及び乳酸等の有機酸又はそれらの塩、リン酸(オルトリン酸)等の無機酸又はそれらの塩(例えば、カリウム塩、ナトリウム塩及びアンモニウム塩)、水酸化ナトリウム、水酸化カリウム等の水酸化物が挙げられる。無機酸塩としては、例えば、リン酸水素二ナトリウム、リン酸二水素ナトリウムが挙げられる。pH調整剤の含有量は、通常、添加後の組成物のpHが5~9、好ましくは6~8.5になる量である。本明細書において、pH値は、通常、測定開始から25℃、3分後の値であり、東亜電波工業社製のpHメーター(型番Hm-30S)を用いて測定できる。
-PH regulator-
When the composition contains a pH adjuster, the pH stability of the pharmaceutical product can be ensured. Examples of the pH adjuster include organic acids such as phthalic acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid, and lactic acid or salts thereof, and inorganic acids such as phosphoric acid (orthoric acid) or salts thereof. (For example, potassium salt, sodium salt and ammonium salt), hydroxides such as sodium hydroxide and potassium hydroxide can be mentioned. Examples of the inorganic acid salt include disodium hydrogen phosphate and sodium dihydrogen phosphate. The content of the pH adjuster is usually such that the pH of the composition after addition is 5 to 9, preferably 6 to 8.5. In the present specification, the pH value is usually a value at 25 ° C. and 3 minutes after the start of measurement, and can be measured using a pH meter (model number Hm-30S) manufactured by Toa Denpa Kogyo Co., Ltd.
-防腐剤-
組成物が防腐剤を含むことにより、製剤の防腐力を確保できる。防腐剤としては、パラオキシ安息香酸エステル(例えば、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸ブチル)、安息香酸ナトリウム等が挙げられる。防腐剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
-Preservative-
When the composition contains a preservative, the antiseptic power of the pharmaceutical product can be ensured. Examples of the preservative include paraoxybenzoic acid esters (for example, methyl paraoxybenzoate, ethyl paraoxybenzoate, butyl paraoxybenzoate), sodium benzoate and the like. The preservative may be used alone or in combination of two or more.
-薬用成分-
薬用成分としては、例えば、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム、イソプロピルメチルフェノール、グルコン酸亜鉛、クエン酸亜鉛、トリクロサン、チモール、ヒノキチオール、塩化リゾチーム等の殺菌又は抗菌剤;デキストラナーゼ、ムタナーゼ、アミラーゼ、プロテアーゼ、リテックエンザイム等の酵素;フッ化ナトリウム、モノフルオロリン酸ナトリウム、フッ化スズ等のフッ化物;ε-アミノカプロン酸、アラントイン、トラネキサム酸、グリチルリチン酸塩(例えば、グリチルリチン2カリウム塩)、グリチルレチン酸、グリチルレチン酸ステアリル、アラントインクロルヒドロキシアルミニウム、アズレン、ジヒドロコレステロール等の抗炎症剤;亜鉛、銅塩、スズ塩等の金属塩;縮合リン酸塩、エタンヒドロキシジホスフォネート等の歯石予防剤;ビタミンE(例えば、酢酸トコフェロール)等の血流促進剤;硝酸カリウム、乳酸アルミニウム、塩化ストロンチウム等の知覚過敏抑制剤;ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド等のコーティング剤;ビタミンC(例えば、アスコルビン酸またはその塩)、塩化リゾチーム、塩化ナトリウム等の収斂剤;銅クロロフィル、グルコン酸銅等の水溶性銅化合物;ゼオライト等の歯石予防剤、アラニン、グリシン、プロリン等のアミノ酸類、タイム、オウゴン、チョウジ、ハマメリス等の植物エキス;カロペプタイド、ポリビニルピロリドンを挙げることができる。薬用成分は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。上記他の有効成分の含有量は、有効量を適宜設定できる。
-Medicated ingredients-
Examples of medicinal ingredients include bactericidal or antibacterial agents such as cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, zinc gluconate, zinc citrate, triclosan, timole, hinokithiol, and lysozyme chloride; Enzymes such as mutanase, amylase, protease, lytecenzyme; fluorides such as sodium fluoride, sodium monofluorophosphate, tin fluoride; ε-aminocaproic acid, allantin, tranexamic acid, glycyrrhizinate (eg, glycyrrhetin dipotassium salt) ), Anti-inflammatory agents such as glycyrrhetinic acid, stearyl glycyrrhetinate, allantinchlorhydroxyaluminum, azulene, dihydrocholesterol; metal salts such as zinc, copper salt, tin salt; tooth stones such as condensed phosphate and ethanehydroxydiphosphonate. Prophylactic agents; blood flow promoters such as vitamin E (eg, tocopherol acetate); hypersensitivity inhibitors such as potassium nitrate, aluminum lactate, strontium chloride; coating agents such as hydroxyethyl cellulose dimethyldiallyl ammonium chloride; vitamin C (eg, ascorbic acid). Or its salt), lysozyme chloride, astringent such as sodium chloride; water-soluble copper compound such as copper chlorophyll, copper gluconate; tooth stone preventive agent such as zeolite, amino acids such as alanine, glycine, proline, thyme, ginger, chowji , Hamamelis and other plant extracts; caropeptide, polyvinylpyrrolidone and the like. The medicinal ingredient may be used alone or in combination of two or more. As for the content of the other active ingredients, the effective amount can be appropriately set.
-溶剤-
溶剤としては、例えば、水、低級1価アルコール(例、エタノール)、これらの混合溶剤が挙げられる。溶剤の配合量は、組成物全量に対し、通常1~90質量%、好ましくは15~80質量%、より好ましくは20~60質量%である。混合溶剤の場合、低級一価アルコールの添加量は、通常組成物中1~30質量%、好ましくは1~20質量%である。
-solvent-
Examples of the solvent include water, lower monohydric alcohol (eg, ethanol), and a mixed solvent thereof. The blending amount of the solvent is usually 1 to 90% by mass, preferably 15 to 80% by mass, and more preferably 20 to 60% by mass with respect to the total amount of the composition. In the case of the mixed solvent, the amount of the lower monohydric alcohol added is usually 1 to 30% by mass, preferably 1 to 20% by mass in the composition.
-他の任意成分-
上記以外の任意成分の例としては、例えば、雲母チタン、酸化チタン、ベントナイト等の無機化合物;カルナバワックス、ロジン、ライスワックス、マイクロクリスタリンワックス、ミツロウ、パラフィンワックス等のワックス類;セタノール、ステアリルアルコール等の高級アルコール;ポリイソブチレン、ポリブタジエン、ウレタン、シリコン、天然ゴムが挙げられる。これらの成分の含有量は、本発明の効果を妨げない範囲で適宜設定できる。
-Other optional ingredients-
Examples of optional components other than the above include inorganic compounds such as mica titanium, titanium oxide, and bentonite; waxes such as carnauba wax, rosin, rice wax, microcrystallin wax, honey wax, and paraffin wax; cetanol, stearyl alcohol, and the like. Higher alcohols; polyisobutylene, polybutadiene, urethane, silicon, natural rubber and the like. The content of these components can be appropriately set as long as the effect of the present invention is not impaired.
本発明の組成物は、練歯磨剤、ジェル状歯磨剤、液状歯磨剤、液体歯磨剤、潤製歯磨剤、粉歯磨剤等の歯磨剤として利用でき、好ましくは練歯磨剤、ジェル状歯磨剤である。 The composition of the present invention can be used as a dentifrice such as a dentifrice, a gel-like dentifrice, a liquid dentifrice, a liquid dentifrice, a dentifrice dentifrice, and a powder dentifrice, preferably a dentifrice or a gel-like dentifrice. Is.
歯磨剤組成物の剤形は、利用形態に応じて適宜選択することができ、特に限定されない。剤形としては、例えば、ゲル状、ペースト状が挙げられる。 The dosage form of the dentifrice composition can be appropriately selected depending on the usage pattern, and is not particularly limited. Examples of the dosage form include a gel form and a paste form.
〔組成物の製造方法〕
歯磨剤組成物の製造方法は特に限定されず、剤形に応じて、それぞれの通常の方法で調製され得る。例えば練歯磨剤として利用する場合、水溶性成分を調製した後、それ以外の成分を混合し、必要に応じて脱泡(例えば、減圧等)を行う方法が挙げられる。得られる練歯磨は、容器に収容して製品とすることができる。容器は、形状、材質は特に制限されず、通常の練歯磨用組成物に使用される容器を使用でき、例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ナイロンなどのプラスチック容器等が挙げられる。
[Method for producing composition]
The method for producing the dentifrice composition is not particularly limited, and can be prepared by each usual method depending on the dosage form. For example, when it is used as a dentifrice, a method of preparing a water-soluble component, mixing the other components, and defoaming (for example, reducing the pressure) as necessary can be mentioned. The obtained toothpaste can be contained in a container and made into a product. The shape and material of the container are not particularly limited, and a container used for a normal toothpaste composition can be used, and examples thereof include plastic containers such as polyethylene, polypropylene, polyethylene terephthalate, and nylon.
[2.口腔内のネバつき抑制剤]
ネバつき抑制剤は、(A)及び(B)成分を含有し、好ましくは(C)及び(D)成分の少なくともいずれかを更に含有し、より好ましくは(A)~(D)成分を含有する。各成分の例、含有量、含有比については前段で述べたのと同様である。
ネバつき抑制剤は、口腔内のネバつきを抑制でき、抑制効果を長期間持続できる。ネバつき抑制剤は、口腔用組成物、好ましくは歯磨剤組成物へ添加されることにより上記効果を効率よく発揮できる。
[2. Anti-stickiness agent in the oral cavity]
The stickiness inhibitor contains components (A) and (B), preferably further contains at least one of components (C) and (D), and more preferably contains components (A) to (D). do. Examples of each component, content, and content ratio are the same as those described in the previous section.
The sticky inhibitor can suppress stickiness in the oral cavity and can maintain the suppressing effect for a long period of time. The stickiness inhibitor can efficiently exert the above effect by being added to the oral composition, preferably the dentifrice composition.
以下、実施例及び比較例を示して本発明を具体的に説明するが、本発明は下記実施例に制限されるものではない。なお、表中の%は特に断らない限り質量%を示す。 Hereinafter, the present invention will be specifically described with reference to Examples and Comparative Examples, but the present invention is not limited to the following Examples. In addition,% in the table shows mass% unless otherwise specified.
[実施例及び比較例に使用した主な原料]
実施例及び比較例において用いた主な原料を下記にまとめて記載する。
(A)ラウロイルサルコシンナトリウム:
日光ケミカルズ(株)製、NIKKOL サルコシネートLN
(B)ピロリン酸ナトリウム:
太平化学産業(株)製
(C)ポリオキシエチレン(20)硬化ヒマシ油:
日本エマルジョン(株)製、HC-20
ポリオキシエチレン(5)ステアリルエーテル:
日本エマルジョン(株)製、605
(D)ポリエチレングリコール:
三洋化成工業(株)製、ポリエチレングリコール400
その他の成分については医薬部外品原料規格2006に適合したものを用いた。
[Main raw materials used in Examples and Comparative Examples]
The main raw materials used in Examples and Comparative Examples are summarized below.
(A) Sodium lauroyl sarcosine:
NIKKOL Sarcocinate LN manufactured by Nikko Chemicals Co., Ltd.
(B) Sodium pyrophosphate:
Taihei Kagaku Sangyo Co., Ltd. (C) Polyoxyethylene (20) Hardened castor oil:
HC-20 manufactured by Nippon Emulsion Co., Ltd.
Polyoxyethylene (5) stearyl ether:
Made by Nippon Emulsion Co., Ltd., 605
(D) Polyethylene glycol:
Polyethylene glycol 400 manufactured by Sanyo Chemical Industries, Ltd.
As for other components, those conforming to the quasi-drug raw material standard 2006 were used.
実施例1~27及び比較例1~2(歯磨剤)
上述の成分を用いて、下記の調製方法に従って、表1~4に示す配合組成(質量部)を有する歯磨用組成物を調製した。
Examples 1-27 and Comparative Examples 1-2 (dentifrice)
Using the above-mentioned components, toothpaste compositions having the compounding compositions (parts by mass) shown in Tables 1 to 4 were prepared according to the following preparation methods.
[歯磨用組成物の調製方法]
精製水に水溶性成分(粘結剤、プロピレングリコール、ソルビットを除く)を溶解させた後、ソルビット液及び増粘性シリカを添加混合し、I液を得た。別途、プロピレングリコールに粘結剤を分散させてII液を得た。次いで、得られたI液にII液を加えて撹拌し、III液を得た。得られたIII液に、香料、研磨剤、界面活性剤等の水溶性成分以外の成分を加え、1.5Lニーダー(石山工作所社製)を用い常温で混合し、減圧(圧力4kPa)による脱泡を行い、歯磨用組成物を得た。
[Preparation method of toothpaste composition]
A water-soluble component (excluding the binder, propylene glycol, and sorbitol) was dissolved in purified water, and then a sorbitol solution and thickening silica were added and mixed to obtain a solution I. Separately, a binder was dispersed in propylene glycol to obtain a liquid II. Then, liquid II was added to the obtained liquid I and stirred to obtain liquid III. Add components other than water-soluble components such as fragrances, abrasives, and surfactants to the obtained solution III, mix at room temperature using a 1.5 L kneader (manufactured by Ishiyama Kosakusho), and reduce the pressure (pressure 4 kPa). Defoaming was performed to obtain a toothpaste composition.
得られた歯磨用組成物を下記の手順で評価した。評価結果を表1~4に示す。 The obtained dentifrice composition was evaluated by the following procedure. The evaluation results are shown in Tables 1 to 4.
<口腔内のネバつき感及び刺激感の評価>
パネラー4名(n=4)による使用感評価を行った。歯ブラシ(クリニカアドバンテージ歯ブラシ、4列コンパクトふつう、ライオン社製)にサンプル1gを乗せ、3分間歯みがきを行ったのち、10mLの水で1回洗口した。口内のネバつき感の有無(使用直後及び2時間後の口腔内のネバつき)、口腔内刺激感(使用直後の口腔内での刺激感)の有無を下記評価基準によって判定し、4名の平均点を求め、下記の評価基準で評価した。
<Evaluation of stickiness and irritation in the oral cavity>
The usability was evaluated by 4 panelists (n = 4). A sample of 1 g was placed on a toothbrush (Clinica Advantage toothbrush, 4-row compact, usually manufactured by Lion), and after brushing the teeth for 3 minutes, the mouth was washed once with 10 mL of water. The presence or absence of stickiness in the mouth (stickiness in the oral cavity immediately after use and 2 hours after use) and the presence or absence of irritation in the oral cavity (stimulation in the oral cavity immediately after use) were judged by the following evaluation criteria, and 4 subjects were judged. The average score was calculated and evaluated according to the following evaluation criteria.
-口内のネバつき感の評価(直後及び2時間後)-
・評点基準
1点:強く感じる
2点:感じる
3点:あまり感じない
4点:ほとんど感じない
5点:全く感じない
・評価基準
◎:4人の平均点が4点以上
○:4人の平均点が3点以上4点未満
×:4人の平均点が3点未満
-Evaluation of stickiness in the mouth (immediately after and 2 hours later)-
・ Scoring criteria 1 point: Feel strongly 2 points: Feel 3 points: Do not feel much 4 points: Almost do not feel 5 points: Do not feel at all ・ Evaluation criteria ◎: Average score of 4 people is 4 points or more ○: Average of 4 people Points are 3 points or more and less than 4 points ×: Average score of 4 people is less than 3 points
-口腔内刺激感-
・評点基準
1点:非常に感じる
2点:感じる
3点:あまり感じない
4点:ほとんど感じない
5点:全く感じない
・評価基準
◎:4人の平均点が4点以上
○:4人の平均点が3点以上4点未満
×:4人の平均点が3点未満
-Mouth irritation-
・ Scoring criteria 1 point: Very feel 2 points: Feel 3 points: Do not feel much 4 points: Almost do not feel 5 points: Do not feel at all ・ Evaluation criteria ◎: Average score of 4 people is 4 points or more ○: 4 people Average score is 3 points or more and less than 4 points ×: Average score of 4 people is less than 3 points
<製剤の保存安定性の評価>
-液分離安定性-
歯磨剤組成物をチューブ容器に収容したものを3本ずつ40℃条件下に1ヶ月保存した後、下記の評点基準で判定し、下記基準で評価した。
・評価基準
◎:液分離が認められない
○:液分離の兆候がごくわずかに認められる(表面に分離の兆候である艶が認められる)が品質上問題ないレベルである
×:液分離が認められる
<Evaluation of storage stability of pharmaceutical product>
-Liquid separation stability-
Three dentifrice compositions contained in a tube container were stored under 40 ° C. conditions for one month, and then judged according to the following scoring criteria and evaluated according to the following criteria.
・ Evaluation criteria ◎: No liquid separation is observed ○: Very few signs of liquid separation are observed (gloss, which is a sign of separation is observed on the surface), but there is no problem in quality ×: Liquid separation is observed Be
-練肌-
歯磨剤組成物をチューブ容器に収容したものを3本ずつ-5℃で1ヶ月間保存した後、下記の評価基準で判定した。
・評価基準
◎:対象品と同等であり、歯磨剤組成物の表面にしわがなく、つやに変化が認められない
○:対象品と比べて、歯磨剤組成物の表面にわずかなしわや表面のつやにわずかな劣化が認められるが、品質上問題ないレベルである
×:対象品と比べて、歯磨剤組成物の表面にしわが認められ、表面につやがなくなり品質上問題であるレベルである
-Kneaded skin-
Three dentifrice compositions contained in a tube container were stored at −5 ° C. for 1 month, and then judged according to the following evaluation criteria.
・ Evaluation criteria ◎: Equivalent to the target product, no wrinkles on the surface of the dentifrice composition, and no change in gloss ○: Slight wrinkles or surface surface of the dentifrice composition compared to the target product Slight deterioration is observed in gloss, but there is no problem in quality. ×: Compared to the target product, wrinkles are observed on the surface of the dentifrice composition, and the surface is not glossy, which is a problem in quality.
〔表1~4の脚注〕
研磨性シリカ:平均粒子径約20μm
[Footnotes in Tables 1 to 4]
Abrasive silica: Average particle diameter of about 20 μm
ラウロイルサルコシンナトリウムを配合しない比較例1、ピロリン酸ナトリウムを配合しない比較例2では口腔内のネバつき感(直後、2時間後)の評価が低かったのに対し、ラウロイルサルコシンナトリウム、ピロリン酸ナトリウムを配合した実施例1~27は、いずれも良好な評価であり、優れた口腔内のネバつき抑制機能を有していた。また、歯磨剤組成物としては、アニオン界面活性剤、ポリエチレングリコールを配合した実施例1~24の歯磨剤組成物では、これらのいずれも、またはいずれかを配合しない実施例25~27の歯磨剤組成物と比較して、刺激感が十分に抑制され、練肌も良好であった。
これらの結果は、本発明が口腔内のネバつき抑制剤として有効に機能し、また本発明の歯磨剤組成物が、口腔内のネバつき防止効果を有しかつ長期間発揮できるので清掃実感が良好であり、さらに好ましい態様では、刺激感が抑制され、良好な外観安定性を有することを示している。
In Comparative Example 1 without sodium lauroyl sarcosine and Comparative Example 2 without sodium pyrophosphate, the evaluation of stickiness in the oral cavity (immediately after 2 hours) was low, whereas sodium lauroyl sarcosine and sodium pyrophosphate were used. All of Examples 1 to 27 that were blended had good evaluations and had an excellent function of suppressing stickiness in the oral cavity. Further, as the dentifrice composition, in the dentifrice compositions of Examples 1 to 24 containing an anionic surfactant and polyethylene glycol, the dentifrices of Examples 25 to 27 not containing any or any of these. Compared with the composition, the irritation sensation was sufficiently suppressed and the dentifrice was also good.
These results show that the present invention effectively functions as an oral anti-stickiness inhibitor, and the dentifrice composition of the present invention has an oral anti-stickiness effect and can be exerted for a long period of time, so that a feeling of cleaning is felt. It is good, and in a more preferable embodiment, it is shown that the irritation feeling is suppressed and the appearance stability is good.
Claims (7)
(B)ピロリン酸アルカリ金属塩
(C)非イオン界面活性剤、及び
(D)ポリエチレングリコール
を含有する歯磨剤組成物。 A dentin composition containing (A) acyl sarcosine or a salt thereof (B) an alkali metal pyrophosphate (C) a nonionic surfactant, and (D) polyethylene glycol.
(B)ピロリン酸アルカリ金属塩
を含有する口腔内のネバつき抑制剤。 An oral anti-stickiness inhibitor containing (A) acylsarcosine or a salt thereof, and (B) an alkali metal pyrophosphate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020152154A JP2022046221A (en) | 2020-09-10 | 2020-09-10 | Dentifrice composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020152154A JP2022046221A (en) | 2020-09-10 | 2020-09-10 | Dentifrice composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2022046221A true JP2022046221A (en) | 2022-03-23 |
Family
ID=80779805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020152154A Pending JP2022046221A (en) | 2020-09-10 | 2020-09-10 | Dentifrice composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2022046221A (en) |
-
2020
- 2020-09-10 JP JP2020152154A patent/JP2022046221A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101052372A (en) | Zinc-containing dentifrice compositions having an improved taste | |
JP5397204B2 (en) | Oral composition | |
JP6981243B2 (en) | Toothpaste composition | |
AU2014414756B2 (en) | Oral care compositions | |
JP7124403B2 (en) | dentifrice composition | |
JP7167659B2 (en) | dentifrice composition | |
CN111902125B (en) | Oral composition and bitterness improver of alpha-olefin sulfonate | |
JP7347916B2 (en) | dentifrice composition | |
JP2022046221A (en) | Dentifrice composition | |
JP7167660B2 (en) | dentifrice composition | |
JP2022062930A (en) | Dentifrice composition | |
CN110621292B (en) | Dentifrice composition | |
KR102531788B1 (en) | Oral composition and method for inhibiting discoloration thereof | |
WO2023277084A1 (en) | Composition for oral cavity | |
JP2022076813A (en) | Composition for oral cavity | |
JPH1135438A (en) | Composition for oral cavity | |
WO2022138487A1 (en) | Oral composition | |
WO2022071593A1 (en) | Dentifrice composition | |
CN116634986A (en) | Oral composition | |
JP2001172145A (en) | Composition for oral cavity | |
CN116669680A (en) | Oral composition | |
JP2024000720A (en) | Composition for oral cavity | |
WO2023063268A1 (en) | Non-aqueous composition for oral cavity | |
WO2022145160A1 (en) | Composition for oral cavity | |
JP2024047742A (en) | Dentifrice Composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230315 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240305 |